Showing results (91-100 of 144) with videos related to
Sort By:
Pageof 15
Annals of Neurology|February 22, 2026
Electrical Impedance Myography Detects Disease Progression over 12 to 24 Months in Facioscapulohumeral Muscular DystrophyKarlien Mul, Michael P McDermott, Russell J Butterfield, et al.Journal of Neuropathology and Experimental Neurology|August 10, 2017
Perry Syndrome: A Distinctive Type of TDP-43 ProteinopathyTakayasu Mishima, Shunsuke Koga, Wen-Lang Lin, et al.Muscle & Nerve|January 5, 2006
Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravisShin J Oh, Yuki Hatanaka, Shoji Hemmi, et al.Muscle & Nerve|April 25, 2020
The care of patients with Duchenne, Becker, and other muscular dystrophies in the COVID-19 pandemicAravindhan Veerapandiyan, Kathryn R Wagner, Susan Apkon, et al.Journal of Neuromuscular Diseases|February 11, 2020
RESTORE: A Prospective Multinational Registry of Patients with Genetically Confirmed Spinal Muscular Atrophy - Rationale and Study DesignRichard S Finkel, John W Day, Darryl C De Vivo, et al.Neurology|January 4, 2020
Safety and efficacy of omaveloxolone in patients with mitochondrial myopathy: MOTOR trialKaren L Madsen, Astrid E Buch, Bruce H Cohen, et al.Muscle & Nerve|May 19, 2022
Quantitative muscle analysis in facioscapulohumeral muscular dystrophy using whole-body fat-referenced MRI: Protocol development, multicenter feasibility, and repeatabilityPer Widholm, André Ahlgren, Markus Karlsson, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|June 30, 2025
Complement activation in a phase Ib study of fordadistrogene movaparvovec for Duchenne muscular dystrophyBarry J Byrne, Russell J Butterfield, Perry B Shieh, et al.Neuromuscular Disorders : NMD|March 8, 2021
Disease-modifying effects of edasalonexent, an NF-κB inhibitor, in young boys with Duchenne muscular dystrophy: Results of the MoveDMD phase 2 and open label extension trialRichard S Finkel, Erika Finanger, Krista Vandenborne, et al.Plos One|September 17, 2015
Transforming Growth Factor Beta (TGF-β) Is a Muscle Biomarker of Disease Progression in ALS and Correlates with Smad ExpressionYing Si, Soojin Kim, Xiangqin Cui, et al.Pageof 15